Transcript to follow
Global governments have no choice but to risk a recession.
Morningstar healthcare analyst Karen Anderson looks at the likely impact of COVID19 on the glo...
After a disastrous 2022, it turned out not to be dead after all.
A mere 1% difference in fees could result in a 240% difference in return over 30 years.
If it's been a while since you looked at your weightings, it might be time for change. Just remem...
Morningstar Announces Winners for 2024 Morningstar Awards for Investing Excellence – Hong Kong
After the run up in the Magnificent Seven stocks, it’s a good time to move back to an underweight...
2023 was a vintage year for Japanese equities, and there are a host of reasons why this can conti...
Stocks correlated to interest rates are expected to perform well this year, according to Mornings...
Vanguard's decision not to offer Bitcoin spot ETFs may raise eyebrows, but Morningstar's John Rek...